In April 2023 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the Athlete after his A and B samples tested positive for the prohibited substances Anastrozole, Drostanolone, Mephentermine, Phentermine and Stanozolol.
Following notification a provisional suspension was ordered and the Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete denied the intentional use of the substances. He was tested for the first time and had already had ceased participating into championships.
The Panel finds that the presence of multiple prohibited substance have been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.
The Panel deems that the Athlete failed to demonstrate that the violation was not intentional, nor how the substances had entered his system. Further the Panel determines that there are aggravating circumstances present in this case for the imposition of a more severe sanction.
Therefore the ADDPI decides on 14 March 2024 to impose a 6 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 12 May 2023.
